Linagliptin API

Holiness Pharmaceutical is a trusted and leading manufacturer and Pharmaceutical API exporter of Linagliptin API, supplying high-quality DPP-4 inhibitor APIs to pharmaceutical companies across 40+ international markets. Linagliptin is widely used for the management of type-2 diabetes mellitus, particularly valued for its glucose-dependent mechanism and renal safety profile, making us a reliable Linagliptin bulk API supplier from India.

Globally, Holiness Pharmaceutical is recognized among the most reputable Linagliptin API manufacturers, offering high assay purity, stringent control of related substances, excellent polymorphic stability, and consistent particle size suitable for oral solid dosage formulations and fixed-dose combinations. Our expertise in incretin-based therapies positions us as a dependable Pharmaceutical API exporter.

Our advanced anti-diabetic API manufacturing facilities operate in strict compliance with international pharmaceutical regulatory standards including:
➡ DCGI, WHO-GMP, US-FDA aligned, and cGMP guidelines,
ensuring validated synthesis routes, robust impurity control, and consistent pharmacopeial compliance for Linagliptin API.

We export Linagliptin API and other chronic-care APIs from India to Asia, Africa, Europe, the Middle East, North America, South America, and CIS regions, supporting formulation manufacturers producing oral antidiabetic therapies and combination products. Holiness Pharmaceutical is widely trusted as a bulk Linagliptin API supplier.

Holiness Pharmaceutical is one of the leading producers of APIs (Active Pharmaceutical Ingredients) and Intermediates, delivering GMP-compliant manufacturing systems, consistent batch quality, and globally accepted regulatory documentation as a certified Pharmaceutical API exporter specializing in metabolic and diabetes APIs.

Holiness Pharmaceutical Ltd manages the complete lifecycle of API development — including R&D innovation, complex heterocyclic synthesis, commercial-scale manufacturing, HPAPI capabilities, and worldwide distribution of APIs and intermediates.

Recognized globally for quality, regulatory reliability, and supply consistency, Holiness Pharmaceutical stands among the top API manufacturers in India, supported by advanced QA/QC laboratories, modern production infrastructure, and a rapidly expanding international supply network as a leading bulk API supplier.

Holiness Pharmaceutical has established a strong presence in many countries including:
United States, Canada, United Kingdom, Germany, France, Netherlands, Italy, Spain, Australia, New Zealand, Slovakia, Estonia, Belarus, Ukraine, Iceland, Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Georgia, Russia, Yemen, Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Turkey, Senegal, Ethiopia, Eswatini, Cameroon, Zambia, Mozambique, Angola, Zimbabwe, Malawi, Seychelles, South Africa, Nigeria, Kenya, Tanzania, Ghana, Egypt, Panama, Costa Rica, El Salvador, Mexico, Brazil, Argentina, Chile, Peru, Colombia, Afghanistan, Bhutan, Cambodia, Vietnam, Indonesia, Philippines, Malaysia, Thailand, South Korea, Japan, Paraguay, Bangladesh.